543 related articles for article (PubMed ID: 32297410)
1. Successful treatment and durable remission of human herpesvirus-8-induced Kaposi sarcoma and multicentric Castleman's disease under valganciclovir in an HIV-negative patient.
Plachouri KM; Oikonomou C; Sarantopoulos A; Koumoundourou D; Georgiou S; Spiliopoulos T
Dermatol Ther; 2020 May; 33(3):e13419. PubMed ID: 32297410
[No Abstract] [Full Text] [Related]
2. Simultaneous Kaposi's sarcoma and Castleman's disease in a HIV-negative patient. Response to rituximab and doxorubicin.
García-Arpa M; Calle-Primo C; Martín-Dávila F
Med Clin (Barc); 2020 Dec; 155(12):565-566. PubMed ID: 31759694
[No Abstract] [Full Text] [Related]
3. Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient.
Murphy C; Hawkes E; Chionh F; Chong G
J Clin Pharm Ther; 2017 Feb; 42(1):111-114. PubMed ID: 27790727
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Ramaswami R; Lurain K; Peer CJ; Serquiña A; Wang V; Widell A; Goncalves P; Steinberg SM; Marshall V; George J; Figg WD; Whitby D; Ziegelbauer J; Uldrick TS; Yarchoan R
Blood; 2020 Jun; 135(25):2316-2319. PubMed ID: 32276276
[No Abstract] [Full Text] [Related]
5. Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV-infected patient under viral suppression.
Lin IF; Lin JN; Tsai TH; Hsu CT; Wu YY; Lai CH
Int J STD AIDS; 2021 Mar; 32(3):286-289. PubMed ID: 33555231
[TBL] [Abstract][Full Text] [Related]
6. [Favorable outcome of Castleman's disease treated with oral valganciclovir].
Valencia ME; Moreno V; Martínez P; Casado I
Med Clin (Barc); 2005 Sep; 125(10):399. PubMed ID: 16185555
[No Abstract] [Full Text] [Related]
7. Valganciclovir in an HIV-infected patient with Castleman's disease.
Marque AS; Sequeira C; Antunes P
Med Clin (Barc); 2020 Oct; 155(8):369-370. PubMed ID: 31488261
[No Abstract] [Full Text] [Related]
8. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Lurain K; Yarchoan R; Uldrick TS
Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution.
Volkow-Fernández P; Lome-Maldonado C; Quintero-Buenrostro H; Islas-Muñoz B; Cornejo-Juárez P
Int J STD AIDS; 2020 Mar; 31(4):318-325. PubMed ID: 32089093
[No Abstract] [Full Text] [Related]
10. Potential heterosexual Kaposi's sarcoma-associated herpesvirus transmission in a couple with HIV-induced immunodepression and with Kaposi's sarcoma and multicentric Castleman's disease.
Tirelli U; Gaidano G; Errante D; Carbone A
AIDS; 1996 Sep; 10(11):1291-2. PubMed ID: 8883593
[No Abstract] [Full Text] [Related]
11. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
[TBL] [Abstract][Full Text] [Related]
12. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
13. Plasma Cell Variant Multicentric Castleman Disease and Kaposi's Sarcoma in a Treatment-Naive HIV-Infected Patient.
Patel AS; Geller RL; Goswami ND
AIDS Res Hum Retroviruses; 2018 Feb; 34(2):127-128. PubMed ID: 29345958
[No Abstract] [Full Text] [Related]
14. Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease.
Siegel MO; Ghafouri S; Ajmera R; Simon GL
Int J Infect Dis; 2016 Jul; 48():49-51. PubMed ID: 27173076
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.
Aoki Y; Tosato G
Expert Rev Anti Infect Ther; 2004 Apr; 2(2):213-25. PubMed ID: 15482187
[TBL] [Abstract][Full Text] [Related]
16. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
Uldrick TS; Polizzotto MN; Aleman K; O'Mahony D; Wyvill KM; Wang V; Marshall V; Pittaluga S; Steinberg SM; Tosato G; Whitby D; Little RF; Yarchoan R
Blood; 2011 Jun; 117(26):6977-86. PubMed ID: 21487108
[TBL] [Abstract][Full Text] [Related]
17. Central pontine myelinolysis complicating treatment of multicentric Castleman's disease and Kaposi's sarcoma in a patient with AIDS.
Apoola A; Ross J; Duddy MJ; Mudaliar V; Jones EL; Huengsberg M; Miller RF
Sex Transm Infect; 2003 Jun; 79(3):179-84. PubMed ID: 12794197
[TBL] [Abstract][Full Text] [Related]
18. HHV8-positive, HIV-negative multicentric Castleman's disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma.
Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A
Int J Hematol; 2009 Oct; 90(3):392-396. PubMed ID: 19756920
[TBL] [Abstract][Full Text] [Related]
19. Putting the pieces together: Castleman disease in a patient with HIV.
Fonseca MR; Teles MO; Barradas AR; Domingos J; Pãosinho A; Madruga I
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):721-723. PubMed ID: 32696874
[No Abstract] [Full Text] [Related]
20. Multicentric Castleman's disease in 2 patients with HIV infection, unresponsive to antiviral therapy.
Bottieau E; Colebunders R; Schroyens W; Van Droogenbroeck J; De Droogh E; Depraetere K; De Raeve H; Van Marck E
Acta Clin Belg; 2000; 55(2):97-101. PubMed ID: 10881375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]